Despite advances in surgery, radiotherapy and chemotherapy, the survival rate of glioma patients remains low, and most patients die of cancer progression within 2 years of diagnosis[2]. According to the World Health Organization (WHO) grading standard, gliomas are divided into four grades (I-IV)...
Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a ... e17594#Background:CA-125 ELIMination Rate Constant K (KELIM) is considered a marker of chemosensitivity in ovarian cancer patients and its...
Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer Purpose: This study was performed to establish the dose-localization capability and acute toxicity of a real-time intraoperative magnetic resonance (MR) im......
Results of the GOG240 study have now been released, indicating that Avastin(R) (bevacizumab) combined with chemother- apy leads to longer overall survival com- pared with chemotherapy alone in patients with advanced cervical cancer.In the study, performed by researchers led by the US Gynecologic ...
Results of the GOG240 study have now been released, indicating that Avastin(R) (bevacizumab) combined with chemother- apy leads to longer overall survival com- pared with chemotherapy alone in patients with advanced cervical cancer.In the study, performed by researchers led by the US Gynecologic ...
(GBM). The majority ofgliomasare malignant and the highmortality rateof patients converts this relatively infrequentmalignancyinto the third leading cause of cancer-related death among men and women of 15–54year old. The mortality ofGBMis especially high with amedian survival timeof 9–12months...
SAAD,F. - 《J Natl Cancer Inst》 被引量: 6864发表: 2002年 Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to...
Most GBM patients have a survival rate of less than two years. There have been cases of patients who have 99% of tumor mass removed, undergo chemotherapy and radiation, but die within a few years because the 1% of cancerous tissue that was not removed was so motile and resilient. In ...
BACKGROUND Esophageal squamous cell carcinoma(ESCC),the predominant type of esophageal cancer,has a 5-year survival rate less than 20%.Although the cause o... Wen-Qian Yang,Rui Liang,Man-Qi Gao,... - 世界胃肠肿瘤学杂志:英文版(电子版) 被引量: 0发表: 2022年 加载更多来源...
Glioblastoma is a highly aggressive and malignant type of brain cancer that originates from glial cells in the brain, with a median survival time of 15 months and a 5-year survival rate of less than 5%. Regulated cell death (RCD) is the autonomous a